Dishman Carbogen Amcis Limited Profit Margin

The latest profit margin for DCAL.BO is 2.98% as of June 2026. That compares with 3.6% in the prior-year period — down 17.2% year over year. That is below the Healthcare sector average of 9.48%. Investors often review this figure alongside Dishman Carbogen Amcis Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, DCAL.BO's profit margin moved from 3.6% to 2.98% — a 17.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Dishman Carbogen Amcis Limited's valuation or profitability profile.

Against Healthcare companies, DCAL.BO currently prints 2.98% for profit margin, while the sector average sits near 9.48%. That is roughly 68.6% below the sector mean. Large gaps often invite a closer look at Dishman Carbogen Amcis Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively Dishman Carbogen Amcis Limited converts resources into returns. At 2.98%, DCAL.BO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 3.6% in the prior-year period — down 17.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting DCAL.BO's profit margin (2.98%), review year-over-year change from 3.6%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.